Arvee Laboratories (India) Share Price

Arvee Laboratories (India) Investment Rating

• Master Rating:

• Arvee Laboratories (India) has an operating revenue of Rs. 40.33 Cr. on a trailing 12-month basis. An annual revenue de-growth of -15% needs improvement, Pre-tax margin of 9% is okay, ROE of 10% is good. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 4% and 0% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 74 which is a FAIR score but needs to improve its earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 68 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.